All good. As for counterintuitive SP movement, yes, it is quite frustrating, given the state of the world and the safety profile of leronlimab, which again is why I place the blame on management to not know how to hire an effective PR firm.

Also, however, the entire stock market is nutso right now, so that's part of it too.